BeOne Medicines Ltd. Investing Cash Flow 2014-2026 | ONC
Beta
What is investing cash flow?
Investing cash flow represents cash used for or generated from investment activities, including capital expenditures, acquisitions, and investment purchases or sales.
What is BeOne Medicines Ltd.'s current investing cash flow?
BeOne Medicines Ltd. (ONC) annual investing cash flow for 2025 was $-276.2M, a 49.64% increase from 2024. BeOne Medicines Ltd. investing cash flow for the quarter ending March 31, 2026 was $-45.5M.
What was BeOne Medicines Ltd.'s investing cash flow in 2024?
BeOne Medicines Ltd. annual investing cash flow for 2024 was $-548.4M, a 1013.86% decline from 2023.
What was BeOne Medicines Ltd.'s investing cash flow in 2023?
BeOne Medicines Ltd. annual investing cash flow for 2023 was $60.0M, a 94.43% decline from 2022.
Investing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-3.17B
→
FY2025
$-276.2M
141516171819202122232425
5 years selected
Investing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-276.2M | +49.6% | 10-K |
| FY2024 | $-548.4M | -1013.9% | 10-K |
| FY2023 | $60.0M | -94.4% | 10-K |
| FY2022 | $1.08B | +68.1% | 10-K |
| FY2021 | $640.7M | +120.2% | 10-K |
| FY2020 | $-3.17B | -671.7% | 10-K |
| FY2019 | $554.2M | +186.9% | 10-K |
| FY2018 | $-637.6M | -78.9% | 10-K |
| FY2017 | $-356.3M | -60.6% | 10-K |
| FY2016 | $-221.8M | -276.6% | 10-K |
| FY2015 | $-58.9M | -75.1% | 10-K |
| FY2014 | $-33.6M | - | 10-K |
Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →